Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction (2013)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- Subjects: REVASCULARIZAÇÃO MIOCÁRDICA; CIRURGIA TORÁCICA; ISQUEMIA MIOCÁRDICA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Circulation
- ISSN: 0009-7322
- Volume/Número/Paginação/Ano: v. 128, n. 22, abst. 10721, 2013
- Conference titles: American Heart Associations of the Scientific Sessions and Resuscitation Science Symposium
-
ABNT
PANZA, Julio A. et al. Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction. Circulation. Dallas: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A10721?sid=6b0e288c-1566-44fe-b492-e72d89bd73f4. Acesso em: 19 abr. 2024. , 2013 -
APA
Panza, J. A., Velazquez, E. J., She, L., Smith, P. K., Nicolau, J. C., Favaloro, R. R., et al. (2013). Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction. Circulation. Dallas: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A10721?sid=6b0e288c-1566-44fe-b492-e72d89bd73f4 -
NLM
Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, Gradinac S, Chrzanowski L, Prabhakaran D, Howlett JG, Jasinski M, Hill JA, Desvigne-Nickens P, Jones RH, Lee KL, Rouleau JL. Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction [Internet]. Circulation. 2013 ; 128( 22):[citado 2024 abr. 19 ] Available from: http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A10721?sid=6b0e288c-1566-44fe-b492-e72d89bd73f4 -
Vancouver
Panza JA, Velazquez EJ, She L, Smith PK, Nicolau JC, Favaloro RR, Gradinac S, Chrzanowski L, Prabhakaran D, Howlett JG, Jasinski M, Hill JA, Desvigne-Nickens P, Jones RH, Lee KL, Rouleau JL. Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction [Internet]. Circulation. 2013 ; 128( 22):[citado 2024 abr. 19 ] Available from: http://circ.ahajournals.org/cgi/content/meeting_abstract/128/22_MeetingAbstracts/A10721?sid=6b0e288c-1566-44fe-b492-e72d89bd73f4 - Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (vol 3, pg 391, 2018)
- Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
- Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
- Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial
- Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
- Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
